Page last updated: 2024-08-21

indazoles and Neuroblastoma

indazoles has been researched along with Neuroblastoma in 28 studies

Research

Studies (28)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's4 (14.29)18.2507
2000's5 (17.86)29.6817
2010's12 (42.86)24.3611
2020's7 (25.00)2.80

Authors

AuthorsStudies
Djos, A; Elfman, LHM; Fransson, S; Gordon Murkes, L; Guan, J; Hallberg, B; Johnsen, JI; Kogner, P; Martinsson, T; Mendoza-García, P; Palmer, RH; Siaw, JT; Stenman, JJE; Treis, D; Umapathy, G; Wessman, S1
Buzdin, AA; Ivanenko, KA; Khabusheva, ER; Kudryavtseva, AV; Lebedev, TD; Mareeva, SR; Morozov, AV; Prassolov, VS; Rubtsov, PM; Snezhkina, AV; Sorokin, MI; Spirin, PV1
Cappabianca, L; Farina, AR; Mackay, AR; Ruggieri, M; Sbaffone, M; Sebastiano, M; Zelli, V1
Binda, C; Catto, M; Delre, P; Gottinger, A; La Spada, G; Latronico, T; Linusson, A; Liuzzi, GM; Mangiatordi, GF; Marchese, S; Mastromarino, M; Miniero, DV; Pisani, L; Rullo, M1
Brodeur, GM; Guan, P; Hu, Y; Iyer, R; Kolla, V; MacFarland, SP; Naraparaju, K; Tan, K1
Alexandre, J; Carmo, H; Carvalho, F; Dias da Silva, D; Malheiro, R; Silva, JP1
Abarbri, M; El Qami, A; Frlan, R; Gobec, S; Jismy, B; Knez, D; Kos, J; Pišlar, A1
Hebron, ML; Javidnia, M; Kinney, NG; Moussa, CE; Xin, Y1
Macy, ME; Pacenta, HL1
Alexe, G; Bandopadhayay, P; Beroukhim, R; Cheff, DM; Chen, L; Conway, A; Davis, MI; Goodale, A; Guha, R; Hall, MD; Iniguez, AB; Johannessen, C; Kitara, S; Lee, Y; Menard, M; Nasholm, N; Pantel, S; Patel, S; Piccioni, F; Qi, J; Robichaud, AL; Roti, G; Stegmaier, K; Stolte, B; Wang, EJ; Weiss, WA1
Bhargava, S; Chen, J; Haas-Kogan, DA; Kolkowitz, I; Matthay, KK; Molinaro, AM; Mueller, S; Olow, A; Orbach, S; Wehmeijer, N; Yang, X1
Aveic, S; Esposito, MR; Li, G; Pantile, M; Seydel, A; Tonini, GP; Zanon, C1
Brodeur, GM; Cam, N; Croucher, JL; Golden, RL; Guan, P; Hornby, Z; Iyer, R; Kolla, V; Li, G; MacFarland, SP; Naraparaju, K; Wehrmann, L; Wei, G1
Glover, CJ; Gransbury, GK; Harris, HH; Hughes, JN; Kappen, P; Lay, PA; Levina, A; Musgrave, IF1
Bawa, O; Bosq, J; Daudigeos-Dubus, E; Geoerger, B; Le Dret, L; Opolon, P; Vassal, G; Vievard, A; Villa, I1
Bravo-San Pedro, JM; Fuentes, JM; González-Polo, RA; Morán, JM; Niso-Santano, M; Ortiz-Ortiz, MA; Soler, G1
Bourredjem, A; Daudigeos-Dubus, E; Farace, F; Geoerger, B; Monnet, Y; Opolon, P; Rössler, J; Vassal, G1
Alcantara, SL; Brzozowski, MJ; Iravani, MM; Jenner, P; Rose, S1
Baruchel, S; Kerbel, RS; Kumar, S; Man, S; Mokhtari, RB; Oliveira, ID; Sheikh, R; Wu, B; Xu, P; Yeger, H; Zhang, L1
Chen, RM; Cheng, HA; Chio, CC; Chiu, WT; Hsing, CH; Lin, JW; Wang, JJ; Wang, YH1
Cho, YS; Chun, YS; Kim, J; Kim, MS; Lee, JC; Park, JW; Yeo, EJ1
Dive, C; Estlin, EJ; Hussein, D; Makin, GW1
Li, G; Li, T; Li, W; Li, Y; Lu, J; Wang, J; Zhao, Y1
Barnes, JM; Barnes, NM1
Barrett, JE; Critchett, D; Hu, W; Sokol, PT; Solomon, AJ; Toral, J; Ziai, MR1
Fukunaga, K; Miyamoto, E; Morishima, Y; Nakayama, W; Omitsu, M; Sato, T; Shirasaki, Y; Sugimura, M1
Fukunaga, K; Miyamoto, E; Ohmitsu, M; Sato, T; Shirasaki, Y; Sugimura, M; Uchida, T1
Grahame-Smith, DG; Leslie, RA; Newberry, NR; Sprosen, TS; Watkins, CJ1

Reviews

1 review(s) available for indazoles and Neuroblastoma

ArticleYear
Entrectinib and other ALK/TRK inhibitors for the treatment of neuroblastoma.
    Drug design, development and therapy, 2018, Volume: 12

    Topics: Anaplastic Lymphoma Kinase; Animals; Benzamides; Humans; Indazoles; Neuroblastoma; Protein Kinase Inhibitors; Receptor Protein-Tyrosine Kinases

2018

Other Studies

27 other study(ies) available for indazoles and Neuroblastoma

ArticleYear
Sustained Response to Entrectinib in an Infant With a Germline ALKAL2 Variant and Refractory Metastatic Neuroblastoma With Chromosomal 2p Gain and Anaplastic Lymphoma Kinase and Tropomyosin Receptor Kinase Activation.
    JCO precision oncology, 2022, Volume: 6

    Topics: Anaplastic Lymphoma Kinase; Benzamides; Chromosomes, Human, Pair 2; Cytokines; Genetic Variation; Germ Cells; Humans; Indazoles; Infant; Male; Neuroblastoma; Protein Kinase Inhibitors; Receptor, trkA

2022
Identification of cell type-specific correlations between ERK activity and cell viability upon treatment with ERK1/2 inhibitors.
    The Journal of biological chemistry, 2022, Volume: 298, Issue:8

    Topics: Aminopyridines; Antineoplastic Agents; Benzamides; Cell Line, Tumor; Cell Survival; Diphenylamine; Humans; Indazoles; MAP Kinase Signaling System; Mitogen-Activated Protein Kinase Kinases; Neuroblastoma; Piperazines; Protein Kinase Inhibitors; Proto-Oncogene Proteins B-raf; Proto-Oncogene Proteins p21(ras); Pyrazoles; Pyridones; Pyrimidines; Pyrroles

2022
Doxorubicin-Induced TrkAIII Activation: A Selection Mechanism for Resistant Dormant Neuroblastoma Cells.
    International journal of molecular sciences, 2022, Sep-17, Volume: 23, Issue:18

    Topics: Alternative Splicing; Benzamides; Calmodulin; Cell Line, Tumor; Crizotinib; Doxorubicin; Humans; Indazoles; Neuroblastoma; Oxygen; Proto-Oncogene Proteins c-akt; Receptor, trkA; Ryanodine Receptor Calcium Release Channel

2022
Bioisosteric replacement based on 1,2,4-oxadiazoles in the discovery of 1H-indazole-bearing neuroprotective MAO B inhibitors.
    European journal of medicinal chemistry, 2023, Jul-05, Volume: 255

    Topics: Humans; Hydrogen Peroxide; Indazoles; Molecular Docking Simulation; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Neuroblastoma; Neuroprotection; Oxadiazoles; Structure-Activity Relationship

2023
Mechanisms of Entrectinib Resistance in a Neuroblastoma Xenograft Model.
    Molecular cancer therapeutics, 2020, Volume: 19, Issue:3

    Topics: Animals; Apoptosis; Benzamides; Biomarkers, Tumor; Cell Proliferation; Drug Resistance, Neoplasm; Gene Expression Regulation, Neoplastic; Humans; Indazoles; Mice; Mice, Nude; Neuroblastoma; Protein Kinase Inhibitors; Proteome; RNA-Seq; Tumor Cells, Cultured; Xenograft Model Antitumor Assays

2020
The Synthetic Cannabinoids THJ-2201 and 5F-PB22 Enhance In Vitro CB
    International journal of molecular sciences, 2020, Aug-30, Volume: 21, Issue:17

    Topics: Animals; Cannabinoid Receptor Agonists; Cell Differentiation; Cell Survival; Glioma; Indazoles; Indoles; Mice; Mitochondria; Naphthalenes; Neuroblastoma; Quinolines; Rats; Receptor, Cannabinoid, CB1; Tumor Cells, Cultured

2020
Pyrimido[1,2-b]indazole derivatives: Selective inhibitors of human monoamine oxidase B with neuroprotective activity.
    European journal of medicinal chemistry, 2021, Jan-01, Volume: 209

    Topics: Antiparkinson Agents; Bromides; Coordination Complexes; Humans; Indazoles; Metals; Molecular Docking Simulation; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Neuroblastoma; Neuroprotective Agents; Protein Binding; Small Molecule Libraries; Structure-Activity Relationship; Tyramine

2021
Pazopanib Reduces Phosphorylated Tau Levels and Alters Astrocytes in a Mouse Model of Tauopathy.
    Journal of Alzheimer's disease : JAD, 2017, Volume: 60, Issue:2

    Topics: Animals; Astrocytes; Calcium-Binding Proteins; Cell Line, Tumor; Cognition; Collagen Type IV; Cytokines; Disease Models, Animal; Dose-Response Relationship, Drug; Female; Glial Fibrillary Acidic Protein; Indazoles; Male; Mice; Mice, Inbred C57BL; Mice, Transgenic; Microfilament Proteins; Motor Activity; Mutation; Neuroblastoma; Phosphorylation; Pyrimidines; Receptors, Vascular Endothelial Growth Factor; RNA, Small Interfering; Silver Staining; Sulfonamides; tau Proteins; Tauopathies; Transfection; Treatment Outcome

2017
Resistance to Epigenetic-Targeted Therapy Engenders Tumor Cell Vulnerabilities Associated with Enhancer Remodeling.
    Cancer cell, 2018, 12-10, Volume: 34, Issue:6

    Topics: Animals; Azepines; Cell Line, Tumor; Disease-Free Survival; Drug Resistance, Neoplasm; Epigenesis, Genetic; Female; Humans; Indazoles; Mice, Nude; Molecular Targeted Therapy; Neuroblastoma; Phosphatidylinositol 3-Kinases; Phosphoinositide-3 Kinase Inhibitors; Proteins; Signal Transduction; Sulfonamides; Triazoles; Xenograft Model Antitumor Assays

2018
Poly (ADP-Ribose) polymerase inhibitor MK-4827 together with radiation as a novel therapy for metastatic neuroblastoma.
    Anticancer research, 2013, Volume: 33, Issue:3

    Topics: Animals; Caspase 3; Cell Line, Tumor; Chemoradiotherapy; Enzyme Inhibitors; Female; Histones; Humans; Indazoles; Mice; Neoplasm Metastasis; Neuroblastoma; Piperidines; Poly(ADP-ribose) Polymerase Inhibitors; Radiation-Sensitizing Agents

2013
Combating autophagy is a strategy to increase cytotoxic effects of novel ALK inhibitor entrectinib in neuroblastoma cells.
    Oncotarget, 2016, Feb-02, Volume: 7, Issue:5

    Topics: Anaplastic Lymphoma Kinase; Apoptosis; Autophagy; Benzamides; Blotting, Western; Cell Cycle; Cell Movement; Cell Proliferation; Fluorescent Antibody Technique; Humans; Immunoenzyme Techniques; Indazoles; Neuroblastoma; Phosphorylation; Real-Time Polymerase Chain Reaction; Receptor Protein-Tyrosine Kinases; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Signal Transduction; Tumor Cells, Cultured; Wound Healing

2016
Entrectinib is a potent inhibitor of Trk-driven neuroblastomas in a xenograft mouse model.
    Cancer letters, 2016, Mar-28, Volume: 372, Issue:2

    Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Benzamides; Camptothecin; Cell Line, Tumor; Cell Proliferation; Dacarbazine; Dose-Response Relationship, Drug; Humans; Indazoles; Irinotecan; Membrane Glycoproteins; Mice, Nude; Neuroblastoma; Protein Kinase Inhibitors; Protein-Tyrosine Kinases; Receptor, trkB; Signal Transduction; Temozolomide; Time Factors; Transfection; Tumor Burden; Xenograft Model Antitumor Assays

2016
Comparison of KP1019 and NAMI-A in tumour-mimetic environments.
    Metallomics : integrated biometal science, 2016, 08-01, Volume: 8, Issue:8

    Topics: Antineoplastic Agents; Dimethyl Sulfoxide; Humans; Hypoxia; Indazoles; Neuroblastoma; Organometallic Compounds; Ruthenium; Ruthenium Compounds; Spheroids, Cellular; Tumor Cells, Cultured; Tumor Microenvironment; X-Ray Absorption Spectroscopy

2016
Dual inhibition using cabozantinib overcomes HGF/MET signaling mediated resistance to pan-VEGFR inhibition in orthotopic and metastatic neuroblastoma tumors.
    International journal of oncology, 2017, Volume: 50, Issue:1

    Topics: Anilides; Animals; Apoptosis; Axitinib; Drug Resistance, Neoplasm; Extracellular Signal-Regulated MAP Kinases; Hepatocyte Growth Factor; Humans; Imidazoles; Indazoles; Mice; Neoplasm Invasiveness; Neuroblastoma; Protein Kinase Inhibitors; Proto-Oncogene Proteins c-met; Pyridines; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factor Receptor-1; Xenograft Model Antitumor Assays

2017
Nitric oxide-mediated toxicity in paraquat-exposed SH-SY5Y cells: a protective role of 7-nitroindazole.
    Neurotoxicity research, 2009, Volume: 16, Issue:2

    Topics: Apoptosis Regulatory Proteins; Cell Cycle Proteins; Cell Death; Cell Line, Tumor; DNA Damage; Dose-Response Relationship, Drug; Drug Interactions; Egtazic Acid; Enzyme Inhibitors; Flow Cytometry; Gene Expression Regulation, Neoplastic; Herbicides; Humans; Indazoles; NADPH Dehydrogenase; Neuroblastoma; Neuroprotective Agents; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase Type II; Nitric Oxide Synthase Type III; Nuclear Proteins; Paraquat; Peroxynitrous Acid; Tetrazolium Salts; Thiazoles; Tumor Suppressor Protein p53

2009
The selective VEGFR1-3 inhibitor axitinib (AG-013736) shows antitumor activity in human neuroblastoma xenografts.
    International journal of cancer, 2011, Jun-01, Volume: 128, Issue:11

    Topics: Animals; Apoptosis; Axitinib; Blotting, Western; Bone Marrow Neoplasms; Child; Drug Synergism; Endothelium, Vascular; Humans; Imidazoles; Indazoles; Male; Mice; Mice, Nude; Neovascularization, Pathologic; Neuroblastoma; Phosphorylation; Sirolimus; Stem Cells; Tumor Cells, Cultured; Vascular Endothelial Growth Factor Receptor-1; Vascular Endothelial Growth Factor Receptor-2; Vascular Endothelial Growth Factor Receptor-3; Xenograft Model Antitumor Assays

2011
The effect of nNOS inhibitors on toxin-induced cell death in dopaminergic cell lines depends on the extent of enzyme expression.
    Brain research, 2011, Aug-02, Volume: 1404

    Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Amidines; Animals; Asparagine; Caspase 3; Cell Death; Cell Line, Tumor; Citrulline; Dopamine; Dopamine Plasma Membrane Transport Proteins; Dose-Response Relationship, Drug; Enzyme Inhibitors; Humans; Indazoles; L-Lactate Dehydrogenase; Leupeptins; Mice; Neuroblastoma; Neurotoxins; Nitric Oxide Synthase Type I; Thiophenes; Transfection; Tritium; Tyrosine 3-Monooxygenase; Vesicular Monoamine Transport Proteins

2011
Metronomic oral topotecan with pazopanib is an active antiangiogenic regimen in mouse models of aggressive pediatric solid tumor.
    Clinical cancer research : an official journal of the American Association for Cancer Research, 2011, Sep-01, Volume: 17, Issue:17

    Topics: Administration, Metronomic; Administration, Oral; Angiogenesis Inhibitors; Animals; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Cell Line, Tumor; Endothelial Cells; Humans; Indazoles; Mice; Mice, Inbred NOD; Mice, SCID; Microvessels; Neoplasms; Neoplastic Cells, Circulating; Neovascularization, Pathologic; Neuroblastoma; Osteosarcoma; Pyrimidines; Random Allocation; Rhabdomyosarcoma; Stem Cells; Sulfonamides; Topoisomerase I Inhibitors; Topotecan; Xenograft Model Antitumor Assays

2011
MicroRNA-210 targets antiapoptotic Bcl-2 expression and mediates hypoxia-induced apoptosis of neuroblastoma cells.
    Archives of toxicology, 2013, Volume: 87, Issue:3

    Topics: 3' Untranslated Regions; Animals; Apoptosis; Binding Sites; Cell Hypoxia; Cell Line, Tumor; Cell Survival; Gene Expression Regulation, Neoplastic; Gene Knockdown Techniques; Glucose; Hypoxia-Inducible Factor 1, alpha Subunit; Indazoles; Mice; MicroRNAs; Neuroblastoma; Neurons; Oxygen; Proto-Oncogene Proteins c-bcl-2; RNA Interference; RNA, Messenger; Time Factors; Transfection

2013
YC-1: a potential anticancer drug targeting hypoxia-inducible factor 1.
    Journal of the National Cancer Institute, 2003, Apr-02, Volume: 95, Issue:7

    Topics: Angiogenesis Inhibitors; Animals; Antineoplastic Agents; Carcinoma; Carcinoma, Hepatocellular; Cell Hypoxia; Culture Media, Conditioned; Endothelial Growth Factors; Enzyme-Linked Immunosorbent Assay; Female; G(M1) Ganglioside; Gene Expression Regulation, Neoplastic; Humans; Hypoxia-Inducible Factor 1, alpha Subunit; Immunoblotting; Indazoles; Intercellular Signaling Peptides and Proteins; Kidney Neoplasms; Killer Cells, Natural; Liver Neoplasms; Lymphokines; Male; Mice; Mice, SCID; Neoplasms; Neovascularization, Pathologic; Neuroblastoma; Platelet Endothelial Cell Adhesion Molecule-1; Precipitin Tests; Rats; Reverse Transcriptase Polymerase Chain Reaction; Stomach Neoplasms; Transcription Factors; Transplantation, Heterologous; Tumor Cells, Cultured; Uterine Cervical Neoplasms; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factors

2003
Chronic hypoxia promotes hypoxia-inducible factor-1alpha-dependent resistance to etoposide and vincristine in neuroblastoma cells.
    Molecular cancer therapeutics, 2006, Volume: 5, Issue:9

    Topics: Apoptosis; Cell Hypoxia; Cell Line, Tumor; Cisplatin; Down-Regulation; Drug Resistance, Neoplasm; Etoposide; Humans; Hypoxia-Inducible Factor 1, alpha Subunit; Indazoles; Neuroblastoma; Proto-Oncogene Proteins c-bcl-2; Vincristine

2006
Regulation of neuronal nitric oxide synthase exon 1f gene expression by nuclear factor-kappaB acetylation in human neuroblastoma cells.
    Journal of neurochemistry, 2007, Volume: 101, Issue:5

    Topics: Acetylation; Cell Line, Tumor; Chromatin Immunoprecipitation; Dose-Response Relationship, Drug; Drug Interactions; Exons; Gene Expression Regulation, Neoplastic; Humans; Hydroxamic Acids; Indazoles; Luciferases; Neuroblastoma; NF-kappa B; Nitric Oxide Synthase Type I; Protein Synthesis Inhibitors; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Time Factors; Transfection

2007
Differential binding characteristics of agonists at 5-HT3 receptor recognition sites in NG108-15 neuroblastoma-glioma cells labelled by [3H]-(S)-zacopride and [3H]granisetron.
    Biochemical pharmacology, 1993, May-25, Volume: 45, Issue:10

    Topics: Animals; Benzamides; Biguanides; Binding Sites; Binding, Competitive; Bridged Bicyclo Compounds; Bridged Bicyclo Compounds, Heterocyclic; Cell Membrane; Glioma; Granisetron; Indazoles; Kinetics; Neuroblastoma; Ondansetron; Quipazine; Receptors, Serotonin; Serotonin; Serotonin Antagonists; Serotonin Receptor Agonists; Tritium

1993
5-HT3 receptor-independent inhibition of the depolarization-induced 86Rb efflux from human neuroblastoma cells, TE671, by ondansetron.
    The Journal of pharmacy and pharmacology, 1995, Volume: 47, Issue:7

    Topics: Anti-Anxiety Agents; Benzamides; Benzofurans; Biguanides; Bridged Bicyclo Compounds, Heterocyclic; Humans; Hypoglycemic Agents; Indazoles; Indoles; Neuroblastoma; Neurotoxins; Ondansetron; Potassium Channels; Receptors, Serotonin; Receptors, Serotonin, 5-HT3; Rubidium Radioisotopes; Serotonin Antagonists; Serotonin Receptor Agonists; Structure-Activity Relationship; Tropanes; Tropisetron; Tumor Cells, Cultured

1995
DY-9760e, a novel calmodulin antagonist with cytoprotective action.
    European journal of pharmacology, 1997, Oct-01, Volume: 336, Issue:1

    Topics: Calcimycin; Calcineurin Inhibitors; Calcium; Calcium-Calmodulin-Dependent Protein Kinases; Calmodulin; Cell Death; Indazoles; Ionophores; Neuroblastoma; Sulfonamides; Tumor Cells, Cultured

1997
Inhibition of neuronal nitric oxide synthase activity by 3-[2-[4-(3-chloro-2-methylphenyl)- 1-piperazinyl]ethyl]-5, 6-dimethoxy-1-(4-imidazolylmethyl)-1H-indazole dihydrochloride 3.5 hydrate (DY-9760e), a novel neuroprotective agent, in vitro and in cultu
    Biochemical pharmacology, 2000, Sep-01, Volume: 60, Issue:5

    Topics: Analysis of Variance; Animals; Calcium-Calmodulin-Dependent Protein Kinase Type 2; Calcium-Calmodulin-Dependent Protein Kinases; Calmodulin; Cell Extracts; Enzyme Inhibitors; Hippocampus; Indazoles; Neuroblastoma; Neurons; Neuroprotective Agents; Nitric Oxide; Nitric Oxide Synthase; Nitric Oxide Synthase Type I; Nitric Oxide Synthase Type II; Nitric Oxide Synthase Type III; Rats; Sulfonamides; Tumor Cells, Cultured

2000
AS-5370 potently antagonizes 5-HT3 receptor-mediated responses on NG108-15 cells and on the rat vagus.
    European journal of pharmacology, 1992, Aug-14, Volume: 219, Issue:1

    Topics: Animals; Azepines; Glioma; Hybrid Cells; In Vitro Techniques; Indazoles; Male; Neuroblastoma; Rats; Rats, Inbred Strains; Serotonin Antagonists; Stereoisomerism; Tubocurarine; Tumor Cells, Cultured; Vagus Nerve

1992